FinscoFinsco

AtriCure (US.ATRC)

Capital Allocation Audit · Period: 2010 – 2026

$Open the interactive terminal to run `audit` and explore all dimensions.→

Key Metrics

US.ATRC · YoY: 2026 H1 vs 2025 H1

MetricValueYoY
FCF Conversion58.1%↑
ROE1.8%↑
Cash Conversion200.8%→
D/E Ratio0.14↑
Gross Margin77.3%→
US.ATRC (AtriCure) | YoY: 2026 H1 vs 2025 H1


Metric            Value  YoY
----------------------------
FCF Conversion    58.1%    ↑
ROE                1.8%    ↑
Cash Conversion  200.8%    →
D/E Ratio          0.14    ↑
Gross Margin      77.3%    →
Key Metrics
US.ATRC (AtriCure) | YoY: 2026 H1 vs 2025 H1
Metric Value YoY
----------------------------
FCF Conversion 58.1% ↑
ROE 1.8% ↑
Cash Conversion 200.8% →
D/E Ratio 0.14 ↑
Gross Margin 77.3% →

Audit Dimensions

Capital FlowReturnsEarning QualityDebt DisciplineMoat

Unlimited Companies

AppleMicrosoftAlphabet-AAmazonNVIDIAMeta PlatformsTeslaBerkshire Hathaway-BJPMorganVisaJohnson & JohnsonWalmartProcter & GambleExxon MobilUnitedHealthHome DepotMasterCardPfizerAbbVieCoca-ColaPepsiCoCostcoNetflixAdvanced Micro DevicesSalesforceDisneyNikeBoeingCaterpillarGoldman SachsAlibabaPDD HoldingsJD.comNIO IncLi AutoBaiduTaiwan SemiconductorASML HoldingEli Lilly and CoBroadcomCiscoOracleIntelAT&TVerizonMerck & CoTexas InstrumentsUnited Parcel ServiceRTX CorpLowe's Companies